Meeder Asset Management’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$19.5K Buy
+261
New +$19.5K ﹤0.01% 524
2023
Q2
Sell
-155
Closed -$12.8K 545
2023
Q1
$12.8K Sell
155
-187
-55% -$15.5K ﹤0.01% 491
2022
Q4
$26.9K Buy
342
+135
+65% +$10.6K ﹤0.01% 585
2022
Q3
$15K Buy
207
+18
+10% +$1.3K ﹤0.01% 1191
2022
Q2
$12K Buy
189
+58
+44% +$3.68K ﹤0.01% 1309
2022
Q1
$8K Buy
131
+94
+254% +$5.74K ﹤0.01% 1632
2021
Q4
$2K Buy
37
+15
+68% +$811 ﹤0.01% 976
2021
Q3
$2K Sell
22
-23
-51% -$2.09K ﹤0.01% 2182
2021
Q2
$3K Sell
45
-253
-85% -$16.9K ﹤0.01% 2100
2021
Q1
$33K Buy
298
+294
+7,350% +$32.6K ﹤0.01% 1241
2020
Q4
$0 Hold
4
﹤0.01% 2020
2020
Q3
$0 Buy
4
+2
+100% ﹤0.01% 2255
2020
Q2
$0 Sell
2
-979
-100% ﹤0.01% 2215
2020
Q1
$98K Buy
981
+280
+40% +$28K 0.01% 723
2019
Q4
$81K Sell
701
-3,366
-83% -$389K ﹤0.01% 854
2019
Q3
$512K Buy
+4,067
New +$512K 0.03% 400
2019
Q2
Sell
-144
Closed -$13K 2073
2019
Q1
$13K Sell
144
-345
-71% -$31.1K ﹤0.01% 1165
2018
Q4
$50K Buy
489
+84
+21% +$8.59K ﹤0.01% 814
2018
Q3
$46K Sell
405
-11,692
-97% -$1.33M ﹤0.01% 801
2018
Q2
$1.08M Buy
12,097
+9,992
+475% +$896K 0.09% 194
2018
Q1
$154K Buy
2,105
+220
+12% +$16.1K 0.01% 482
2017
Q4
$110K Buy
1,885
+1,821
+2,845% +$106K 0.01% 549
2017
Q3
$3K Buy
+64
New +$3K ﹤0.01% 1373